Biofrontera AG (B8FGn.F)

B8FGn.F on Frankfurt Stock Exchange

2.73EUR
29 Jul 2014
Price Change (% chg)

€0.04 (+1.60%)
Prev Close
€2.69
Open
€2.67
Day's High
€2.73
Day's Low
€2.67
Volume
400
Avg. Vol
4,291
52-wk High
€4.20
52-wk Low
€2.53

B8FGn.F

Chart for B8FGn.F

About

Biofrontera AG is a Germany-based biopharmaceutical company that develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its product portfolio includes: Ameluz, launched on the market for photodynamic therapy (PDT) of actinic keratoses, and under development for other... (more)

Overall

Beta: 0.96
Market Cap (Mil.): €60.40
Shares Outstanding (Mil.): 22.20
Dividend: --
Yield (%): --

Financials

  B8FGn.F Industry Sector
P/E (TTM): -- 107.05 36.29
EPS (TTM): -0.50 -- --
ROI: -- -0.60 18.13
ROE: -- -1.65 18.95
Search Stocks

Earnings vs. Estimates

Search Stocks